Logo image of SGRP

SPAR GROUP INC (SGRP) Stock Fundamental Analysis

USA - NASDAQ:SGRP - US7849331035 - Common Stock

1.17 USD
+0.05 (+4.46%)
Last: 9/18/2025, 8:23:53 PM
1.14 USD
-0.03 (-2.56%)
After Hours: 9/11/2025, 8:13:51 PM
Fundamental Rating

2

Taking everything into account, SGRP scores 2 out of 10 in our fundamental rating. SGRP was compared to 99 industry peers in the Media industry. SGRP may be in some trouble as it scores bad on both profitability and health. SGRP is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SGRP has reported negative net income.
SGRP had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SGRP reported negative net income in multiple years.
In multiple years SGRP reported negative operating cash flow during the last 5 years.
SGRP Yearly Net Income VS EBIT VS OCF VS FCFSGRP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

With a Return On Assets value of -18.09%, SGRP is not doing good in the industry: 71.72% of the companies in the same industry are doing better.
SGRP's Return On Equity of -52.00% is on the low side compared to the rest of the industry. SGRP is outperformed by 67.68% of its industry peers.
Industry RankSector Rank
ROA -18.09%
ROE -52%
ROIC N/A
ROA(3y)-0.67%
ROA(5y)0%
ROE(3y)-0.75%
ROE(5y)0.79%
ROIC(3y)N/A
ROIC(5y)N/A
SGRP Yearly ROA, ROE, ROICSGRP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

The Gross Margin of SGRP (21.79%) is worse than 72.73% of its industry peers.
In the last couple of years the Gross Margin of SGRP has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for SGRP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.7%
GM growth 5Y0.05%
SGRP Yearly Profit, Operating, Gross MarginsSGRP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

3

2. Health

2.1 Basic Checks

SGRP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SGRP has less shares outstanding
The number of shares outstanding for SGRP has been increased compared to 5 years ago.
SGRP has a worse debt/assets ratio than last year.
SGRP Yearly Shares OutstandingSGRP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SGRP Yearly Total Debt VS Total AssetsSGRP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.69 indicates that SGRP is not a great score, but indicates only limited risk for bankruptcy at the moment.
SGRP has a better Altman-Z score (2.69) than 78.79% of its industry peers.
A Debt/Equity ratio of 1.06 is on the high side and indicates that SGRP has dependencies on debt financing.
With a Debt to Equity ratio value of 1.06, SGRP perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Altman-Z 2.69
ROIC/WACCN/A
WACC8.27%
SGRP Yearly LT Debt VS Equity VS FCFSGRP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

SGRP has a Current Ratio of 1.36. This is a normal value and indicates that SGRP is financially healthy and should not expect problems in meeting its short term obligations.
SGRP has a Current ratio (1.36) which is in line with its industry peers.
SGRP has a Quick Ratio of 1.36. This is a normal value and indicates that SGRP is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.36, SGRP perfoms like the industry average, outperforming 56.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.36
SGRP Yearly Current Assets VS Current LiabilitesSGRP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SGRP have decreased strongly by -159.41% in the last year.
Looking at the last year, SGRP shows a very negative growth in Revenue. The Revenue has decreased by -44.47% in the last year.
SGRP shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.89% yearly.
EPS 1Y (TTM)-159.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-44.47%
Revenue growth 3Y-8.36%
Revenue growth 5Y-4.89%
Sales Q2Q%-32.57%

3.2 Future

The Earnings Per Share is expected to grow by 112.71% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y221.19%
EPS Next 2Y112.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-16.91%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SGRP Yearly Revenue VS EstimatesSGRP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SGRP Yearly EPS VS EstimatesSGRP Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.1 -0.1 0.2 0.3 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SGRP. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 4.59, which indicates a rather cheap valuation of SGRP.
Based on the Price/Forward Earnings ratio, SGRP is valued cheaper than 93.94% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.88. SGRP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 4.59
SGRP Price Earnings VS Forward Price EarningsSGRP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SGRP Per share dataSGRP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SGRP's earnings are expected to grow with 112.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y112.71%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SGRP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPAR GROUP INC

NASDAQ:SGRP (9/18/2025, 8:23:53 PM)

After market: 1.14 -0.03 (-2.56%)

1.17

+0.05 (+4.46%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-12 2025-08-12
Earnings (Next)11-12 2025-11-12
Inst Owners10.94%
Inst Owner Change-17.93%
Ins Owners1.36%
Ins Owner Change6.96%
Market Cap27.44M
Analysts82.86
Price TargetN/A
Short Float %1.66%
Short Ratio0.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.16%
Min Revenue beat(2)-22.39%
Max Revenue beat(2)-13.93%
Revenue beat(4)0
Avg Revenue beat(4)-16.26%
Min Revenue beat(4)-22.39%
Max Revenue beat(4)-11.79%
Revenue beat(8)2
Avg Revenue beat(8)-0.23%
Revenue beat(12)4
Avg Revenue beat(12)-1.37%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.59
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 1.18
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)0.26
Fwd EY21.79%
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS6.12
BVpS1.06
TBVpS0.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.09%
ROE -52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.79%
FCFM N/A
ROA(3y)-0.67%
ROA(5y)0%
ROE(3y)-0.75%
ROE(5y)0.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.7%
GM growth 5Y0.05%
F-Score2
Asset Turnover2.01
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 91.59%
Cap/Sales 0.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.36
Altman-Z 2.69
F-Score2
WACC8.27%
ROIC/WACCN/A
Cap/Depr(3y)73.74%
Cap/Depr(5y)75.81%
Cap/Sales(3y)0.58%
Cap/Sales(5y)0.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-159.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y221.19%
EPS Next 2Y112.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.47%
Revenue growth 3Y-8.36%
Revenue growth 5Y-4.89%
Sales Q2Q%-32.57%
Revenue Next Year-16.91%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-125.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-501.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-343.5%
OCF growth 3YN/A
OCF growth 5YN/A